Offerings // Evommune, Inc.

EVMN offering history

Every offering-related filing in Evommune, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 138 filings back to Jan 7, 2025.

Last executed offering

Nov 4, 2026

8-K — priced deal (shares or notes)

Last registration (announced)

Apr 17, 2026

S-1 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Nov 4, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 4, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 9, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 6, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 29, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 2, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 7, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 24, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 24, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 17, 2026	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Feb 13, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 6, 2025	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Nov 6, 2025	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Oct 30, 2025	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Oct 17, 2025	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Oct 9, 2025	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

EVMN offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full EVMN workspace →

EVMN offering FAQ

When did EVMN last execute an offering?

Per SEC filings, Evommune, Inc.'s most recent priced offering document is a 8-K filed 2026-11-04. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did EVMN last announce or register an offering?

The most recent registration is a S-1 filed 2026-04-17. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.